Delivery Order SPE2DB20D3103-SPE2DB24FN2W5
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for $2,046.17. The order is for Abilify Maintena ER 400 mg syringes, a medication used to treat mental health conditions. The order has a firm fixed price and a completion date of July 7, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The award, valued at $3,346.48, is for the supply of Abilify Maintena ER 400 mg syringes, a specialty pharmaceutical product. The order is placed under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 and is valid through December 2025. This IDC serves as a primary vehicle for Amerisourcebergen to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,635.14 firm fixed-price contract is for the delivery of Abilify Maintena ER 300 mg syringes. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Abilify Maintena ER 400 mg vials. The contract has a firm fixed-price pricing type and a ceiling value of $5,853.96. The delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999, for providing a comprehensive range of medical commodities to support military...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Abilify Maintena ER 400 mg VLS. The contract has a firm fixed price of $1,672.33 and a completion date of May 21, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $4,731.25 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of 4,564,248,487 units of Abilify Maintena ER 400 mg syringes. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,919.51 firm-fixed-price contract is for the supply of ABILIFY MAINTENA ER 400 MG SYRS, a prescription medication. The delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,850.36 firm fixed-price contract is for the delivery of ABILIFY MAINTENA ER 400 MG SYRS, a specialty pharmaceutical product. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,927.45, is for the delivery of ABILIFY MAINTENA ER 400 MG SYRS, a specialty pharmaceutical product. The contract has a completion date of May 14, 2024 and is a firm fixed-price contract. The contract is not associated with a set-aside program and appears to be an open competition award....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Abilify Maintena ER 400 mg syringes under a firm fixed-price contract with a ceiling value of $2,287.19. Awarded on September 23, 2025, this non-set-aside delivery order is scheduled for completion by September 24, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction within the company's broader...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB24FN2W5Delivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Abilify Maintena ER 400 mg syringes. The $8,366.20 firm fixed-price contract has an ultimate completion date of April 4, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. This delivery order is intended to meet the medical needs of military personnel, veterans, and other federal beneficiaries through the DLA's centralized procurement of essential pharmaceutical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.4k | 4/3/24 |